Initial [18F]DCFPyL PET/CT in treatment-na ïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence
ConclusionOur study revealed that pretreatment [18F]DCFPyL uptake in primary or metastatic tumor sites is prognostically relevant in high-risk PCa patients undergoing ADT.Further research is needed to develop robust predictive models in this multifaceted landscape of PCa management.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Hormonal Therapy | Hormones | Nuclear Medicine | PET Scan | Prostate Cancer | Study